Saila Antila - Concepedia

Author

Saila Antila

Orion Corporation (Finland)

Also Known As

S Antila, S. Antila, Saila Antila

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Orion Corporation (Finland)Helsinki University Hospital University of Helsinki East Tallinn Central Hospital Orion Corporation (United Kingdom)

About

Saila Antila is an author at Orion Corporation (Finland) specializing in pharmacology, medicine, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	561
2	Biochemistry	3	3	140
3	Natural Sciences	1	1	34
4	Social Sciences	1	1	18
5	Biomolecular Engineering	1	1	28

Saila Antila

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with severe heart failure Matti Kivikko, Saila Antila, Jaan Eha, International Journal of Clinical Pharmacology and Therapeutics	2002	198
Pharmacodynamics and Safety of a New Calcium Sensitizer, Levosimendan, and Its Metabolites during an Extended Infusion in Patients with Severe Heart Failure Matti Kivikko, Saila Antila, Jaan Eha, The Journal of Clinical Pharmacology	2002	127
Pharmacokinetics of Levosimendan in Healthy Volunteers and Patients with Congestive Heart Failure Esa-Pekka Sandell, Marja Häyhä, Saila Antila, Journal of Cardiovascular Pharmacology Heart FailureSteady StateOral LevosimendanHealthy VolunteersPharmacology	1995	100
Pharmacokinetics of Levosimendan in Healthy Volunteers and Patients with Congestive Heart Failure Esa-Pekka Sandell, Marja Häyhä, Saila Antila, Journal of Cardiovascular Pharmacology Therapeutic Drug MonitoringHeart FailureSteady StateOral LevosimendanHealthy Volunteers	1995	91
Pharmacokinetics of levosimendan in pediatric patients evaluated for cardiac surgery Maila Turanlahti, Talvikki Boldt, T. Palkama, Pediatric Critical Care Medicine	2004	81
Pharmacokinetics of levosimendan and its active metabolite OR-1896 in rapid and slow acetylators Saila Antila, Ullamari Pesonen, Lasse Lehtonen, European Journal of Pharmaceutical Sciences Active Metabolite Or-1896Pharmacological StudyBiochemistryMedicinePharmacotherapy	2004	70
Pharmacokinetics of levosimendan and its circulating metabolites in patients with heart failure after an extended continuous infusion of levosimendan Saila Antila, Matti Kivikko, Lasse Lehtonen, British Journal of Clinical Pharmacology	2004	68
Site dependent bioavailability and metabolism of levosimendan in dogs Saila Antila, Hannele Huuskonen, Timo Nevalainen, European Journal of Pharmaceutical Sciences Animal PhysiologyVeterinary PhysiologyMedicinePhysiologyVeterinary Science	1999	53
Integrated pharmacokinetics and pharmacodynamics of the novel calcium sensitizer levosimendan as assessed by systolic time intervals. S. Sundberg, Saila Antila, Harry Scheinin, PubMed	1998	43
Population pharmacokinetics of levosimendan in patients with congestive heart failure E. Niclas Jonsson, Saila Antila, Lynn McFadyen, British Journal of Clinical Pharmacology	2003	40

Page 1